Chesney Castleberry

Impact of HeartWare VAD discontinuation on the pediatric population: An ACTION registry analysis

The HeartWare ventricular assist device (HVAD) was discontinued in July 2021. The study aims to describe the impact the discontinuation the HVAD had on pediatric ventricular assist device (VAD) utilization and outcomes.

Outcomes after initial heart failure consultation in Fontan patients

ACTION Publication, Publications

Patients with Fontan failure are high-risk candidates for heart transplantation and other advanced therapies. Understanding the outcomes following initial heart failure consultation can help define appropriate timing of referral for advanced heart failure care.